de Arajo MR, Meneses GC, Carioca AAF, Martins AMC, Daher EDF, da Silva Junior GB (2023) Use of probiotics in patients with chronic kidney disease on hemodialysis: a randomized clinical trial
Purity, potency, and consistency are real safety issues, particularly for injectable products. She says that at a minimum, safeguards should include ingredient sourcing, supplier qualification, identity testing, purity, potency, sterility, endotoxin testing, stability, labeling, and adverse event reporting
Category 2 substances have been identified as presenting potential safety risks
These observations imply that Epithalon might enhance oocyte survival by potentially mitigating oxidative damage and preserving genomic stability